CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
CN Stock MarketDetailed Quotes
688273 Nanjing Medlander Medical Technology
- 28.45
- +1.04+3.79%
Market Closed Apr 30 15:00 CST
2.85BMarket Cap27.04P/E (TTM)
28.77High27.28Low17.72KlotVolume27.44Open27.41Pre Close50.23MTurnover4.81%Turnover Ratio28.00P/E (Static)100.00MShares32.7052wk High2.11P/B1.05BFloat Cap17.9852wk Low32.89Limit Up36.83MShs Float48.30Historical High21.93Limit Down5.44%Amplitude16.66Historical Low1.00Dividend TTM28.35Avg Price5.94KlotAsk3.51%Div YieldTTM100Lot Size10.38KlotBid
Nanjing Medlander Medical Technology Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 13.36%118.28M | 24.57%424.55M | 13.81%330.58M | 11.73%228.38M | -4.39%104.34M | -9.57%340.82M | -2.64%290.46M | 11.61%204.4M | 46.34%109.12M | 10.32%376.89M |
| Operating revenue | 13.36%118.28M | 24.57%424.55M | 13.81%330.58M | 11.73%228.38M | -4.39%104.34M | -9.57%340.82M | -2.64%290.46M | 11.61%204.4M | 46.34%109.12M | 10.32%376.89M |
| Total operating cost | 17.34%79.13M | 17.16%322.31M | 5.34%232.3M | -2.64%153.78M | -15.24%67.44M | 1.14%275.11M | 4.06%220.53M | 14.09%157.96M | 50.40%79.57M | 15.15%272.01M |
| Operating cost | 27.36%34.48M | 20.89%119.04M | 6.83%91.4M | -4.79%61.66M | -32.73%27.07M | -16.93%98.47M | -13.23%85.56M | -4.83%64.77M | 100.86%40.24M | 28.15%118.53M |
| Operating tax surcharges | 12.81%585.73K | -4.24%4.74M | -14.87%3.07M | -22.89%2.06M | -52.77%519.22K | 16.44%4.95M | 23.00%3.61M | 45.67%2.68M | 27.52%1.1M | -13.86%4.25M |
| Operating expense | -8.71%18.09M | 13.51%93.68M | 0.26%66.28M | 0.44%44.46M | 3.46%19.82M | -1.92%82.53M | 6.41%66.11M | 15.69%44.27M | 9.35%19.15M | 14.11%84.14M |
| Administration expense | 11.09%12.09M | 22.87%55.68M | 15.35%38.26M | 11.70%25.25M | 10.81%10.89M | 38.51%45.31M | 44.82%33.17M | 63.14%22.6M | 48.67%9.82M | 15.10%32.72M |
| Financial expense | 84.41%-592.23K | 43.35%-8.15M | 31.99%-7.33M | -17.57%-6.07M | -32.26%-3.8M | -60.54%-14.38M | -310.31%-10.78M | -201.60%-5.16M | -317.58%-2.87M | -1,406.77%-8.96M |
| -Interest expense (Financial expense) | 58.14%288.67K | 178.69%1.06M | 142.89%763.43K | 107.29%443.7K | 66.73%182.54K | 26.59%380.94K | 67.33%314.31K | 65.81%214.04K | 68.75%109.48K | 97.07%300.94K |
| -Interest Income (Financial expense) | 76.88%-922K | 38.07%-9.21M | 27.01%-8.13M | -21.24%-6.52M | -32.72%-3.99M | -59.75%-14.87M | -377.79%-11.14M | -190.50%-5.38M | -295.70%-3M | -1,092.45%-9.31M |
| Research and development | 11.82%14.48M | -1.56%57.33M | -5.23%40.62M | -8.29%26.42M | 6.78%12.95M | 40.89%58.24M | 53.18%42.86M | 58.75%28.81M | 41.40%12.13M | 11.04%41.34M |
| Credit Impairment Loss | 16.52%-361.46K | -109.81%-1.36M | -351.82%-853.14K | -658.02%-998.86K | -116.32%-433K | 77.81%-647.63K | 85.09%-188.82K | 88.05%-131.77K | -43.99%-200.17K | -437.71%-2.92M |
| Asset Impairment Loss | ---- | -2,047.64%-9.82M | ---- | ---- | ---- | -31.11%-457.18K | ---- | ---- | ---- | -106.15%-348.71K |
| Other net revenue | ||||||||||
| Fair value change income | 289.36%643.93K | 55.98%1.02M | 219.71%1.13M | 37.29%496.15K | ---340.05K | --652.16K | --352.12K | 157.93%361.39K | ---- | ---- |
| Invest income | -24.96%1.02M | -70.84%4.05M | -79.56%2.17M | -80.38%1.61M | -71.76%1.36M | 74.28%13.89M | 158.63%10.63M | 532.57%8.19M | 1,108.21%4.82M | 67.17%7.97M |
| -Including: Investment income associates | -614.85%-746.63K | -152.48%-869.1K | -60.48%-495.23K | -0.75%-217.1K | 26.95%-104.45K | -903.44%-344.22K | -366.39%-308.6K | -240.61%-215.49K | -305.34%-142.99K | 37.37%42.84K |
| Asset deal income | ---- | -152.02%-122.18K | -6,751.93%-248.24K | ---- | ---- | --234.85K | --3.73K | ---- | ---- | ---- |
| Other revenue | -41.41%2.67M | -20.11%18.46M | -23.77%12.9M | -18.71%9.68M | 25.69%4.56M | -36.33%23.1M | -41.00%16.92M | 0.24%11.91M | 36.79%3.63M | 79.36%36.28M |
| Operating profit | 2.56%43.13M | 11.69%114.46M | 16.11%113.37M | 27.87%85.39M | 11.23%42.05M | -29.74%102.48M | -17.20%97.64M | 17.35%66.78M | 53.81%37.8M | 12.19%145.86M |
| Add:Non operating Income | 254.66%38.98K | 12,264.01%11.34M | 93.49%156.61K | 2.22%61.25K | -17.92%10.99K | -15.66%91.76K | -13.94%80.94K | -20.47%59.92K | -55.15%13.39K | 709.47%108.8K |
| Less:Non operating expense | 490.19%204.56 | -38.03%678.59K | 53.20%466.77K | 48.80%223.12K | -99.41%34.66 | 1,458.28%1.1M | 4,156.15%304.67K | 1,284.89%149.94K | 181.39%5.86K | -75.78%70.28K |
| Total profit | 2.62%43.16M | 23.30%125.13M | 16.06%113.06M | 27.80%85.23M | 11.23%42.06M | -30.44%101.48M | -17.45%97.42M | 17.06%66.69M | 53.67%37.81M | 12.46%145.9M |
| Less:Income tax cost | 0.20%3.88M | 80.37%16.23M | 15.54%12.53M | 54.64%9.32M | -12.36%3.87M | -45.83%9M | -8.09%10.85M | 7.31%6.03M | 111.71%4.42M | 65.47%16.61M |
| Net profit | 2.87%39.28M | 17.75%108.9M | 16.13%100.53M | 25.13%75.91M | 14.36%38.19M | -28.47%92.48M | -18.49%86.57M | 18.13%60.66M | 48.29%33.39M | 8.01%129.29M |
| Net profit from continuing operation | 2.87%39.28M | 17.75%108.9M | 16.13%100.53M | 25.13%75.91M | 14.36%38.19M | -28.47%92.48M | -18.49%86.57M | 18.13%60.66M | 48.29%33.39M | 8.01%129.29M |
| Less:Minority Profit | -130.30%-576.04K | 174.46%7.32M | 143.46%4.46M | 81.51%3.3M | 88.74%1.9M | -64.93%2.67M | -77.41%1.83M | -61.13%1.82M | -29.76%1.01M | 478.51%7.6M |
| Net profit of parent company owners | 9.85%39.86M | 13.10%101.58M | 13.37%96.07M | 23.39%72.61M | 12.04%36.29M | -26.19%89.82M | -13.62%84.74M | 26.08%58.84M | 53.60%32.39M | 2.79%121.68M |
| Earning per share | ||||||||||
| Basic earning per share | 11.28%0.4073 | 14.77%1.0309 | 15.19%0.9728 | 24.97%0.7331 | 13.00%0.366 | -38.49%0.8982 | -33.04%0.8445 | -5.74%0.5866 | 15.23%0.3239 | -7.49%1.4602 |
| Diluted earning per share | 11.28%0.4073 | 14.77%1.0309 | 15.19%0.9728 | 24.97%0.7331 | 13.00%0.366 | -38.49%0.8982 | -33.04%0.8445 | -5.74%0.5866 | 15.23%0.3239 | -7.49%1.4602 |
| Other composite income | ||||||||||
| Total composite income | 2.87%39.28M | 17.75%108.9M | 16.13%100.53M | 25.13%75.91M | 14.36%38.19M | -28.47%92.48M | -18.49%86.57M | 18.13%60.66M | 48.29%33.39M | 8.01%129.29M |
| Total composite income of parent company owners | 9.85%39.86M | 13.10%101.58M | 13.37%96.07M | 23.39%72.61M | 12.04%36.29M | -26.19%89.82M | -13.62%84.74M | 26.08%58.84M | 53.60%32.39M | 2.79%121.68M |
| Total composite income of minority owners | -130.30%-576.04K | 174.46%7.32M | 143.46%4.46M | 81.51%3.3M | 88.74%1.9M | -64.93%2.67M | -77.41%1.83M | -61.13%1.82M | -29.76%1.01M | 478.51%7.6M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | -- |
| Auditor | -- | -- | -- | -- | -- | Tianheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianheng Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.